Regional lymph node classification for lung cancer staging

Chest

Volumn 111, Issue 6, 1997, Pages 1718-1723

  Mountain, Clifton F ^a   Dresler, Carolyn M ^b  

^a UCSD MEDICAL CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

Lung cancer; Lymph node classification; Lymph node mapping; Staging; Survival rates

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG HILUS; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0030926263     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.6.1718     Document Type: Article

References (23)

1. American Joint Committee on Cancer. Lung. In: Beahrs OH, Hensen DE, Hutter RVP, et al, eds. Manual for staging cancer. 4th ed. Philadelphia: Lippincott, 1992; 115-21
2. American Thoracic Society. Clinical staging of primaiy lung cancer. Am Rev Respir Dis 1983; 127:1-6
3. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S-33S
4. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111:1710-17
5. Naruke T, Suemasu K. Surgical treatment for lung cancer with metastasis to mediastinal lymph nodes. J Thorac Cardiovasc Surg 1976; 71:279-85
6. Naruke T, Suemasu K, Ishikawa S. Lymph node mapping and curability of various levels of metastases in resected lung cancer. J Thorac Cardiovasc Surg 1978; 76:832-39
7. Naruke T. Significance of lymph node metastasis in lung cancer. Semin Thorac Cardiovasc Surg 1993; 5:210-18
8. Glazer GM, Gross BH, Quint LE, et al. Normal mediastinal lymph nodes: number and size according to American Thoracic Society mapping. AJR Am J Roentgenol 1985; 144: 261-65
9. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992; 182:319-23
10. Scott WJ, Gobar LS, Terry JD, et al. Mediastinal lymph node staging of non-small-cell lung cancer - a prospective comparison of computed tomography and positron emission tomography. J Thorac Cardiovasc Surg 1996; 111:642-48
11. Heller SM. Mediastinal lymph node dissection. In: Pass HI, Mitchell JB, Johnson DH, et al, eds. Lung cancer: principles and practice. Philadelphia: Lippincott-Raven, 1996; 546-55
12. Mountain CF, Libshitz HI, Hermes KE. Lung cancer: a handbook for staging and imaging. Houston: Mountain and Libshitz, 1996; 4-5
13. Naruke T, Goya T, Tsuchiva R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988; 96:440-47
14. Martini N. The role of surgery in N1 and N2 lung cancer. In: Meyer JL, ed. The lymphatic system and cancer. Radiat Ther Oncol 1994; 18:91-101
15. Izibicki JR, Thetter O, Habekost M, et al. Radical systemic mediastinal lymphadenectomy in non-small cell lung cancer: a randomized controlled trial. Br J Surg 1994; 81:229-35
16. Naruke T. Mediastinal lymph node dissection. In: Pearson FG, DesLauriers J, Ginsberg RJ, et al, eds. Thoracic surgery. New York: Churchill-Livingston, 1995; 909-17
17. Martini N. Mediastinal lymph node dissection for lung cancer: The Memorial experience. Chest Surg Clin North Am 1995; 5:189-203
18. Maggi G, Casadio C, Mancuso M, et al. Resection and radical lymphadenectomy for lung cancer: prognostic significance of lymphatic metastases. Int Surg 1990; 75:17-21
19. Conill C, Astudillo J, Verger E. Prognostic significance of metastases to mediastinal lymph node levels in resected non-small cell lung carcinoma. Cancer 1992; 72:1199-1202
20. Mountain CF. Surgery for stage IIIa-N2 non-small cell lung cancer. Cancer 1994; 73:2589-98
21. Theunissen PH, Bollen EC, Koudstaal J, et al. Intranodal and extranodal tumor growth in early metastasized non-small cell lung cancer: problems in histological diagnosis. J Clin Pathol 1994; 47:920-23
22. Sauter ER, Gwin JL, Mandel J, et al. p53 and disease progression in patients with non-small cell lung cancer. Surg Oncol 1995; 4:157-61
23. Gehan EA. Statistical methods for survival time studies. In: Staque MJ, ed. Cancer therapy, prognostic factors and criteria of response. New York: Raven, 1975; 7-35